{"id":1222,"date":"2024-04-29T16:25:46","date_gmt":"2024-04-29T15:25:46","guid":{"rendered":"https:\/\/oxfordhealth.nhs.uk\/research\/?page_id=1222"},"modified":"2026-08-06T14:51:57","modified_gmt":"2026-08-06T13:51:57","slug":"previous-research","status":"publish","type":"page","link":"https:\/\/oxfordhealth.nhs.uk\/research\/themes\/research-results-and-keeping-in-touch\/previous-research\/","title":{"rendered":"Previous Research"},"content":{"rendered":"<p>There are many ways to get involved with research at Oxford Health NHS Foundation Trust.<\/p>\n<p>We are hugely grateful to all those people who take part in our research and want to give participants the opportunity to be updated on the outcomes of the studies they have been involved with.<\/p>\n<p>To do this we are building a library of short articles summarising completed studies and their outcomes (see below).<\/p>\n<p>This resource will be added to regularly over the coming months so please check back later for further updates.<\/p>\n<h2><strong>Dementia and Brain Health<\/strong><\/h2>\n<details class=\"nhsuk-details\">\n                    <summary class=\"nhsuk-details__summary\">\n                        <span class=\"nhsuk-details__summary-text\">2024: Optimising Online Peer Support for People with Young Onset Dementia<\/span>\n                    <\/summary>\n                    <div class=\"nhsuk-details__text\">\n<p>People with Young Onset Dementia (YOD) can be hesitant to engage with online peer support. This work aims to explore (1) why people are hesitant to engage in online peer support, (2) how to get more people involved in online peer support, and (3) what makes online peer support work well. Nine interviews with people with YOD were conducted on MS Teams. Participants were recruited through purposive sampling. Data were analysed thematically. Reasons for being hesitant to engage with online peer support include being unsure what to expect and concerns about seeing others in more advanced stages of dementia. Additionally, it can be difficult to identify groups that suit one\u2019s needs and interests. Group facilitators of online peer support groups should provide a detailed description of their group so that people can better assess whether the group would suit them. The insights obtained from this study will be used to develop a Best Practice Guidance on online peer support for people with YOD. Moreover, the findings can be useful for further research exploring how to support people with dementia in general in accessing online health and social care services.<\/p>\n<p><a href=\"https:\/\/www.mdpi.com\/1660-4601\/21\/1\/60\">Read the full article<\/a>: Published 2024,\u00a0<em>International Journal of Environmental Research and Public Health<\/em><\/p>\n<\/div>\n                <\/details>\n<details class=\"nhsuk-details\">\n                    <summary class=\"nhsuk-details__summary\">\n                        <span class=\"nhsuk-details__summary-text\">2024: SONNET: Social connection in long-term care homes: a qualitative study of barriers and facilitators<\/span>\n                    <\/summary>\n                    <div class=\"nhsuk-details__text\">\n<p>Social connection is a basic human need and is essential to quality of life. It is associated with better mental and physical health outcomes for long-term care (LTC) home residents and is a key aspect of quality of care and person-centred care. There are considerations for LTC homes that may present obstacles to and opportunities for social connection. It is therefore important to understand what restricts or enables good social connection in LTC homes, to guide better quality care and future interventions in this population. This qualitative study aims to identify barriers and facilitators to social connection for LTC residents.<\/p>\n<p><a href=\"https:\/\/bmcgeriatr.biomedcentral.com\/articles\/10.1186\/s12877-024-05454-8\">Read the full article<\/a>: Published 2024,\u00a0<em>BMC Geriatrics\u00a0<\/em><\/p>\n<\/div>\n                <\/details>\n<details class=\"nhsuk-details\">\n                    <summary class=\"nhsuk-details__summary\">\n                        <span class=\"nhsuk-details__summary-text\">2024: IDEAL: Correlates of Felt Age in Caregivers of People with Dementia: Findings from the IDEAL Study<\/span>\n                    <\/summary>\n                    <div class=\"nhsuk-details__text\">\n<p><strong>How old do carers of people with dementia feel and why? <\/strong><\/p>\n<p>Most adults feel younger than their actual age. Few adults feel as old as they actually are, or older. Those who feel older than their actual age generally experience low mood and poor health. We wondered how carers of people with dementia feel about their age.<\/p>\n<p>We wanted to find out:<\/p>\n<ul>\n<li>How old carers of people with dementia feel<\/li>\n<li>Whether carers who feel older than their actual age have poor health and low mood<\/li>\n<li>What is different about carers who feel older than their actual age?<\/li>\n<\/ul>\n<p>To answer these questions researchers spoke with 1,247 carers of people with dementia.<\/p>\n<p>One in four carers felt older than their actual age. These carers had lower mood and poorer health. They were spending more hours helping the person with dementia and felt more stressed.<\/p>\n<p>Asking carers what age they feel can help identify those who are doing less well.<\/p>\n<p><strong><a href=\"https:\/\/doi.org\/10.3389\/fpsyg.2023.1287842\">Read the full article<\/a>:<\/strong> Published January 2024, <em>Frontiers in Psychology Journal<\/em><\/p>\n<\/div>\n                <\/details>\n<details class=\"nhsuk-details\">\n                    <summary class=\"nhsuk-details__summary\">\n                        <span class=\"nhsuk-details__summary-text\">2024: PATHFINDER: Information about the results of the PATHFINDER trial<\/span>\n                    <\/summary>\n                    <div class=\"nhsuk-details__text\">\n<p>The study investigated whether a talking therapy, called Problem Adaptation Therapy, could improve the symptoms of depression in people with Alzheimer\u2019s disease.<\/p>\n<p>A total of 336 people with Alzheimer\u2019s disease and those who help to look after them participated in the study. Half were randomly allocated to receive up to 8 sessions of Problem Adaptation Therapy and half were allocated to receive just their usual care and to act as a comparison for the Therapy. Everyone in the study was followed for 12 months and asked to complete tests of their mood and quality of life.<\/p>\n<p>The Study showed that people who received the Problem Adaptation Therapy showed a small improvement in their symptoms of depression and overall quality of life compared with those who did not have the therapy. Unfortunately, these benefits were only fairly short-lived.<\/p>\n<p>We will use the results of the Study to develop a longer form of Problem Adaptation Therapy that can be used to support people with dementia and their families and to improve symptoms of depression.<\/p>\n<p>Thank you again for helping by your participation in the research. Without studies like PATHFINDER it would not be possible to develop better ways to help and treat people with dementia and to make their lives and those of the people who love and support them better.<\/p>\n<p><strong><a href=\"https:\/\/alz-journals.onlinelibrary.wiley.com\/doi\/10.1002\/alz.13766\">Read the full article<\/a>:<\/strong> Published March 2024, <em>Journal of Alzheimer\u2019s Association<\/em><\/p>\n<\/div>\n                <\/details>\n<details class=\"nhsuk-details\">\n                    <summary class=\"nhsuk-details__summary\">\n                        <span class=\"nhsuk-details__summary-text\">2024: IDEAL: Health conditions in spousal caregivers of people with dementia and their relationships with stress, caregiving experiences, and social networks: longitudinal findings from the IDEAL programme<\/span>\n                    <\/summary>\n                    <div class=\"nhsuk-details__text\">\n<p><strong>What difference do health problems make to carers of people with dementia?<\/strong><\/p>\n<p>Many older people support a spouse who is living with dementia. Caring in this way can be demanding, especially when carers have health problems themselves.<\/p>\n<p>We wanted to find out more about these health problems and how they change over time. We also wanted to find out whether carers who are in poor health feel more stressed or have less contact with friends and family.<\/p>\n<p>We spoke to over 900 people caring for spouses with dementia at home in Great Britain three times over a two-year period. They told us about their health, how stressed they felt, and how much contact they had with family and friends.<\/p>\n<p>Most carers had one or two health conditions. This was the same for men and women, but older carers and carers who had less education had more health problems.<\/p>\n<p>Having more health conditions went along with feeling more stressed. Over time, it meant people had less contact with friends and family.<\/p>\n<p>Taking care of your own health while looking after a person with dementia can be challenging, but it is important for carers to look after their own health needs, and for health professionals to check up on carers\u2019 health.<\/p>\n<p><strong><a href=\"https:\/\/doi.org\/10.1186\/s12877-024-04707-w\">Read the full article<\/a>:<\/strong> Published February 2024, <em>BMC Geriatrics Journal<\/em><\/p>\n<\/div>\n                <\/details>\n<details class=\"nhsuk-details\">\n                    <summary class=\"nhsuk-details__summary\">\n                        <span class=\"nhsuk-details__summary-text\"> 2023: HOMESIDE: Home-based music therapy for persons with dementia and their spouses as primary caregivers<\/span>\n                    <\/summary>\n                    <div class=\"nhsuk-details__text\">\n<p>Music therapy has been found to be an effective intervention for persons with dementia (PWD) and their primary caregivers (PC), yet the implementation of musical strategies to improve daily care in the home environment requires further exploration. This study developed and examined a home-based music therapy (HBMT) work model that offers weekly joint music therapy sessions, and additional bi-weekly phone-counseling sessions with the PC. This was followed by an additional 12-week support period that included 3 therapy sessions and 3 phone counseling sessions once every other fortnight, so that the same type of session occurred at a frequency of once a month. Participants were five couples (PWD\u2009+\u2009spouse as PC) who live in their home. Findings based on the qualitative multiple case study research method showed the importance of the music therapist\u2019s (MT) continuous support. The MT\u2019s presence made it possible to address the needs of both spouses, separately and together, while maintaining the required balance. Moreover, the MT\u2019s presence enabled better implementation of the musical strategies independently and this was maintained during the intervention and the support period.<\/p>\n<p><a href=\"https:\/\/www.frontiersin.org\/journals\/public-health\/articles\/10.3389\/fpubh.2023.1250689\/full\">Read the full article<\/a>: Published 2023,\u00a0<em>Frontiers in Public Health<\/em><\/p>\n<\/div>\n                <\/details>\n<details class=\"nhsuk-details\">\n                    <summary class=\"nhsuk-details__summary\">\n                        <span class=\"nhsuk-details__summary-text\">2023: IDEAL: Caring beyond capacity\u2019 during the coronavirus pandemic: resilience and family carers of people with dementia from the IDEAL cohort<\/span>\n                    <\/summary>\n                    <div class=\"nhsuk-details__text\">\n<p><strong>What was it like for family carers of people with dementia one year into the COVID-19 pandemic?<\/strong><\/p>\n<p>We interviewed seven family carers of people with dementia in 2021. We were interested in their experiences one year into the COVID-19 pandemic and after the vaccine had been introduced. We were also interested in thinking about how resilient they were, and why. All but one person was caring for a spouse or partner. One person was a daughter caring for her mother. Everyone we spoke to was living with the family member they cared for. Our youngest family carer was 53, and our oldest was 89.<\/p>\n<p>People told us what it was like caring for their family member during a later stage of the pandemic. They said that they still had to protect the person they cared for by avoiding the risk of COVID-19. Some were taking \u201csmall steps\u201d in going out again. Earlier in the pandemic, one person had stopped paid carers coming in, saying: \u201cwe didn\u2019t want [COVID-19] brought into the house for us\u201d. Some people felt that their family member had declined. This was because they had not been able to go out. People wanted to care for their loved ones, but caring for a family member with dementia could be quite an intense role. One person said: \u201cI live at a high level of adrenalin much of the time\u201d. People also had little or no time to pursue their own interests. Two people found it difficult to combine caring with full-time work. Because of social restrictions, people were also caring in isolation. Family members could not offer support in person.<\/p>\n<p>Not everyone we spoke to said they felt stressed, but some people said they felt \u2018burned out\u2019 and abandoned. They had been caring beyond their capacity. People said no one had been \u2018checking in\u2019 on them except for charity volunteers telephoning them. Later in the pandemic, some people said there were fewer of these phone calls. Also, groups like dementia caf\u00e9s had not restarted yet. Day care and respite care were also still absent or limited. One person spoke about needing to access respite care but felt guilty about this: \u201c\u2026if I could, I would spare [my partner] the kind of abandonment. But on the other hand, I \u2026 I would not trust myself to be \u2026 to keep going forever\u201d. Another person was told he would need to wait for six months to get a health and social care assessment for his wife. People also said that lack of support from health and social care was nothing new, but the pandemic seemed to have made this worse. Even before the pandemic, people said that their family members had not had much follow up after their dementia diagnosis. Mostly families seem to have been managing on their own.<\/p>\n<p>Family carers want to care for their loved ones with dementia but this can be difficult. Their experiences during the pandemic have further exposed why appropriate service support is so important. Without it, family members are caring on their own and may \u2018burn out\u2019. Some researchers think we should try to make family carers better able to withstand this kind of stress. We argue that trying to make individual carers more mentally resilient is insufficient on its own. To support family carers of people with dementia, there needs to be sustained support from services after diagnosis and improved access to appropriate health and social care. Family carers\u2019 own needs, separate from their caring role, also need to be considered.<\/p>\n<p><strong><a href=\"https:\/\/doi.org\/10.1332\/239788221X16819328227036\">Read the full article<\/a>:<\/strong> Published May 2023, <em>International Journal of Care and Caring<\/em><\/p>\n<\/div>\n                <\/details>\n<details class=\"nhsuk-details\">\n                    <summary class=\"nhsuk-details__summary\">\n                        <span class=\"nhsuk-details__summary-text\">2023: IDEAL: Dyadic perspectives on loneliness and social isolation among people with dementia and spousal carers: findings from the IDEAL programme<\/span>\n                    <\/summary>\n                    <div class=\"nhsuk-details__text\">\n<p><strong>If a person feels lonely or isolated, does this affect their partner? <\/strong><\/p>\n<p>We spoke to 1,042 people with dementia and carers who were either married couples or living together as partners. We asked them about:<\/p>\n<ul>\n<li>feeling lonely<\/li>\n<li>how much contact they had with family and friends, to see whether they were isolated<\/li>\n<li>how they felt about their relationship<\/li>\n<li>how they felt about their lives.<\/li>\n<\/ul>\n<p>We found that:<\/p>\n<ul>\n<li>if a person with dementia or a carer feels lonely, they may feel less happy about their life<\/li>\n<li>if a carer feels lonely, this can sometimes affect how happy the person with dementia feels about their life<\/li>\n<li>if a person with dementia sees fewer people, this can sometimes make the carer feel less happy about their life<\/li>\n<\/ul>\n<p>How people with dementia and carers feel about their relationship also makes a difference. If people feel closer to their partner, both they and their partner are less affected by loneliness or isolation.<\/p>\n<p>If one person in a couple feels lonely or sees fewer people it can affect the other person\u2019s life, too. It is important for health and social care services to consider the experiences of both the person with dementia and the carer.<\/p>\n<p><strong><a href=\"https:\/\/doi.org\/10.1080\/13607863.2023.2286618\">Read the full article<\/a>:<\/strong> Published December 2023, <em>Aging &amp; Mental Health Journal<\/em><\/p>\n<\/div>\n                <\/details>\n<details class=\"nhsuk-details\">\n                    <summary class=\"nhsuk-details__summary\">\n                        <span class=\"nhsuk-details__summary-text\">2023: IDEAL: Trajectories of cognitive and perceived functional decline in people with dementia. Findings from the IDEAL programme<\/span>\n                    <\/summary>\n                    <div class=\"nhsuk-details__text\">\n<p>Dementia makes it harder for people to remember. Dementia also makes it harder for people to do everyday tasks like shopping, cleaning, and dressing.<\/p>\n<p>We asked 1537 people with dementia to tell us how well they could do these kinds of tasks. We also asked them to do a memory test. We asked 1266 family carers to rate how well they thought the person with dementia was able to do these everyday tasks. We collected this same information three times over two years.<\/p>\n<p>We found that people with the most memory problems said that they had the most problems with everyday tasks. Family carers also said this. As time went on, we found that memory problems grew. We also found that problems with everyday tasks increased.<\/p>\n<p>Ratings from people with dementia suggest that problems in everyday tasks increased as memory problems increased. On the other hand, ratings from family carers suggest that problems in everyday tasks increased much more than problems with memory.<\/p>\n<p>This tells us that people with dementia have a good idea of the problems they experience with everyday tasks. They were good at recognising that changes in their ability to do these tasks was linked to how their memory changes.<\/p>\n<p>This also tells us that family carers think problems with everyday tasks increase more quickly than problems with memory. This might be because other things, like stress for example, affect how carers rate ability in everyday tasks.<\/p>\n<p>It is important to listen to the opinions of both the person with dementia and the carer. People with dementia can tell health and social care professionals how things are going to get the right support. Carers who identify a lot of difficulties could be offered further support to help them cope.<\/p>\n<p><strong><a href=\"https:\/\/doi.org\/10.1002\/alz.13448\">Read the full article<\/a>:<\/strong> Published September 2023, <em>Alzheimer\u2019s &amp; Dementia Journal<\/em><\/p>\n<\/div>\n                <\/details>\n<details class=\"nhsuk-details\">\n                    <summary class=\"nhsuk-details__summary\">\n                        <span class=\"nhsuk-details__summary-text\">2023: IDEAL: Dyadic influences on awareness of condition in people with dementia: Findings from the IDEAL cohort<\/span>\n                    <\/summary>\n                    <div class=\"nhsuk-details__text\">\n<p><strong>Do people with dementia and carers see everyday problems in the same way?<\/strong><\/p>\n<p>People with dementia can have problems with everyday activities. This could mean they have problems remembering things, thinking clearly, making decisions, or doing everyday tasks.<\/p>\n<p>We wanted to know if the family carer of a person with dementia sees the same problems as the person with dementia. If they see things differently, we wanted to find out why.<\/p>\n<p>We talked to couples where one person had dementia and the other person was their spouse. We asked both people in the couple to say which of a list of everyday problems the person with dementia had. We looked at the difference between the two sets of answers. We also looked at the carer\u2019s answers alone.<\/p>\n<p>Female carers tended to list more problems than male carers. Female carers also felt more stressed.<\/p>\n<p>People with dementia tended to say fewer everyday problems than their carers did. When there was a big difference in how they saw things, the carer was usually more stressed. When the difference in how they saw things was smaller, the person with dementia tended to feel more depressed.<\/p>\n<p>This tells us that it is important to listen to both the person with dementia and their carer when it comes to everyday problems. Understanding how each member of the couple sees things can help professionals better understand the situation and provide more personalised support.<\/p>\n<p><strong><a href=\"https:\/\/doi.org\/10.3389\/fnagi.2023.1277336\">Read the full article<\/a>:<\/strong> Published December 2023, <em>Frontiers in Aging Neuroscience Journal<\/em><\/p>\n<\/div>\n                <\/details>\n<details class=\"nhsuk-details\">\n                    <summary class=\"nhsuk-details__summary\">\n                        <span class=\"nhsuk-details__summary-text\">2023: IDEAL: Navigating the coronavirus pandemic two years on: Experiences of people with dementia from the British IDEAL cohort<\/span>\n                    <\/summary>\n                    <div class=\"nhsuk-details__text\">\n<p><strong>How have people with dementia coped with the COVID-19 restrictions over time?<\/strong><\/p>\n<p>Early in the pandemic, people with dementia faced unique challenges. The COVID-19 rules stopped people doing their usual activities. These activities normally gave people with dementia a sense of purpose and helped them to live independently. Having less contact with people caused problems with getting the right health support, worsened mood, and made people worried about their dementia getting worse.<\/p>\n<p>We wanted to know if the problems people experienced early in the pandemic would be the same two years later. We wanted to know how people with dementia were coping. The new rules allowed everyone to go out more. However, many services had not returned to normal. There was a new wave of infections from the \u2018Omicron\u2019 variant.<\/p>\n<p>We re-interviewed nine people we had spoken to earlier in the pandemic. We wanted to understand what life was like for them and how they were doing at this point.<\/p>\n<p>Five people had young-onset dementia and were aged between 51 and 68 years old. The other four people living with dementia were aged between 71 and 89. There were similar numbers of people living alone and living with a spouse or partner.<\/p>\n<p>We found three common themes across the interviews:<\/p>\n<ol>\n<li>Navigating a changing world<\/li>\n<li>A downward spiral<\/li>\n<li>Access to support<\/li>\n<\/ol>\n<p>The first theme was \u2018navigating a changing world\u2019. People were not comfortable with mixing because they felt unsafe. However, people also wanted to live fuller lives again. They did this by \u2018navigating\u2019 the situation and still taking precautions like wearing masks or restricting face-to-face contact.<\/p>\n<p>A second theme was \u2018a downward spiral\u2019. In earlier interviews, people had concerns about their dementia getting worse. Now, people noticed changes in their skills, and were less confident. Although this made it more difficult to do some things, people did what they could to practice their skills.<\/p>\n<p>The third theme was about \u2018access to support\u2019. Some people felt they could get the support they needed and others did not. Being in contact with family or friends, or having good neighbours, made things easier.<\/p>\n<p>Many health and social services remained closed or were only available online. Some people struggled to get appointments. Although some had received medical help by phone or by using the internet, not everyone found this useful.<\/p>\n<p>People with dementia continued to struggle even after social restrictions had eased. It is important to understand who may be in most need of help. Support groups and health services need to be available in ways that allow more people to access them.<\/p>\n<p><strong><a href=\"https:\/\/doi.org\/10.1177\/14713012231158215\">Read the full article<\/a>:<\/strong> Published February 2023, <em>Dementia Journal<\/em><\/p>\n<\/div>\n                <\/details>\n<details class=\"nhsuk-details\">\n                    <summary class=\"nhsuk-details__summary\">\n                        <span class=\"nhsuk-details__summary-text\">2023: IDEAL: The precariousness of living with, and caring for people with, dementia: Insights from the IDEAL programme<\/span>\n                    <\/summary>\n                    <div class=\"nhsuk-details__text\">\n<p><strong>How do feelings of uncertainty affect people living with dementia? <\/strong><\/p>\n<p>Many people face insecurity and uncertainty in their lives due to circumstances they cannot control. This could make it harder to cope when living with dementia or caring for someone with dementia.<\/p>\n<p>We spoke with 20 people with dementia and their family carers about their experiences. They were all part of the larger IDEAL study. We purposely spoke to people who were different from each other. Some felt positive about life, some negative. Some lived in a rural area, some in an urban area. We also had a range of ages, socio-economic backgrounds and a good gender balance.<\/p>\n<p>Researchers sometimes call feelings of insecurity and uncertainty \u2018precarity\u2019 and study how precarity affects different people. We wanted to explore how feelings of insecurity and uncertainty affect people living with dementia and carers. We wanted to understand which uncertainties arose from dementia. We also thought there might be things about people\u2019s situations before dementia entered their lives which could make them feel more insecure or uncertain.<\/p>\n<p>Some people experienced a lot of insecurity and uncertainty. They felt vulnerable. We found four themes:<\/p>\n<ol>\n<li>Feeling unsure about how the symptoms of dementia would progress<\/li>\n<li>Worrying whether they would be able to access the care and support they needed in the future<\/li>\n<li>Trying to stay independent even if that was getting harder<\/li>\n<li>Lots of different worries building up together These things made it harder for them to manage.<\/li>\n<\/ol>\n<p>Some uncertainties were due to dementia, like worrying about symptoms. Others were about systems beyond people\u2019s control, such as benefits and finances. Some worries were to do with beliefs, like remaining independent.<\/p>\n<p>Lots of different things affect the experience of living with dementia. We need to remember that caring is difficult and that our needs change. People would manage better if they felt more confident that they would get the support they need.<\/p>\n<p><strong><a href=\"https:\/\/doi.org\/10.1016\/j.socscimed.2023.116098\">Read the full article<\/a>:<\/strong> Published July 2023, <em>Social Science &amp; Medicine Journal<\/em><\/p>\n<\/div>\n                <\/details>\n<details class=\"nhsuk-details\">\n                    <summary class=\"nhsuk-details__summary\">\n                        <span class=\"nhsuk-details__summary-text\">2023: IDEAL: The precariousness of living with, and caring for people with, dementia: Insights from the IDEAL programme<\/span>\n                    <\/summary>\n                    <div class=\"nhsuk-details__text\">\n<p><strong>Do personality traits affect how people with dementia and their carers feel about their lives?<\/strong><\/p>\n<p>A personality trait is a lifelong characteristic that affects how a person thinks, feels, and behaves. There are five main traits, which reflect how outgoing, organized, creative, cooperative, and relaxed a person is.<\/p>\n<p>We wanted to find out if having different levels of these traits affected how people with dementia and carers felt about their lives. We looked at this when they joined the IDEAL study and over the next two years.<\/p>\n<p>We spoke to over 1,500 people with dementia and 1,200 carers. They told us how much each trait described them when they joined the IDEAL study. They also answered questions about their quality of life, satisfaction with life, and well-being. In addition, people with dementia completed a memory test and carers told us how stressed they were feeling. We asked for this information again one and two years later.<\/p>\n<p>All five traits influenced how people with dementia felt about their lives. Those who were more outgoing, organized, creative, cooperative, and relaxed had a more positive view of their lives than those with lower levels of these traits.<\/p>\n<p>Carers who were more relaxed, outgoing, and organized had a more positive view of their life than those with lower levels of these traits. How creative or cooperative they were did not affect how they felt about their lives.<\/p>\n<p>People tended to feel the same way about their lives over the two years of the study. There was not much change. Where feelings did change, it was not due to differences in personality traits.<\/p>\n<p><strong><a href=\"https:\/\/doi.org\/10.1186\/s12877-023-04075-x\">Read the full article<\/a>:<\/strong> Published June 2023, <em>BMC Geriatrics Journal<\/em><\/p>\n<\/div>\n                <\/details>\n<details class=\"nhsuk-details\">\n                    <summary class=\"nhsuk-details__summary\">\n                        <span class=\"nhsuk-details__summary-text\">2023: IDEAL: Resilience in carers of people with mild-to-moderate dementia: findings from the IDEAL cohort<\/span>\n                    <\/summary>\n                    <div class=\"nhsuk-details__text\">\n<p><strong>What makes a difference to coping with caring? <\/strong><\/p>\n<p>Carers are family members, friends, or other supporters who provide help and support to people with dementia. Supporting a person with dementia can be demanding. Some carers find it easier than others to cope with these demands.<\/p>\n<p>We wanted to find out how carers are coping with these tasks and why others are not coping so well.<\/p>\n<p>We asked 1,222 carers some questions about how they were coping. We also asked them about themselves and about the person with dementia. To measure coping we created a coping score based on the answers people gave to five questionnaires.<\/p>\n<p>Older carers and male carers were most likely to be coping well. Certain things led to carers coping better:<\/p>\n<ul>\n<li>If they had a good relationship with the person with dementia<\/li>\n<li>If they felt they were doing a good job of caring<\/li>\n<li>If they were less inclined to worry<\/li>\n<li>If they were able to go out more<\/li>\n<\/ul>\n<p>Carers also coped better if the person with dementia:<\/p>\n<ul>\n<li>Was older<\/li>\n<li>Felt more positive<\/li>\n<li>Had only minor difficulty with everyday tasks like shopping, cleaning, and getting dressed.<\/li>\n<\/ul>\n<p>Overall, carers of people with mild-to-moderate dementia are coping well with their caring roles. However, it is always important to make sure that carers are receiving the support they need as a carer.<\/p>\n<p><strong><a href=\"https:\/\/doi.org\/10.1186\/s12877-023-04549-y\">Read the full article<\/a>:<\/strong> Published December 2023, <em>BMC Geriatrics Journal<\/em><\/p>\n<\/div>\n                <\/details>\n<details class=\"nhsuk-details\">\n                    <summary class=\"nhsuk-details__summary\">\n                        <span class=\"nhsuk-details__summary-text\">2022: The IDEAL Cohort Study: Use and costs of services and unpaid care for people with mild-to-moderate dementia: baseline results from the IDEAL cohort study<\/span>\n                    <\/summary>\n                    <div class=\"nhsuk-details__text\">\n<p>This study uses data from the IDEAL programme, which is a large research project that aims to find out what helps people to \u2018live well\u2019 with dementia. Over 1,500 people with mild-to-moderate dementia (MMSE&gt;14) and their carers were interviewed as part of the programme. The interviews included questions on people\u2019s use of health and social services, out-of-pocket payments for equipment and travel to appointments and unpaid care provided by family and friends.<\/p>\n<p>The average total costs of health and social care, out-of-pocket payments and unpaid care were estimated at \u00a34,008 per person with dementia over a 3 month period, equivalent to over \u00a316,000 a year. The estimated cost for the use of health and social care services over 3 months was \u00a31,004. Most people used few health services other than GP services and hospital outpatient care, and use of social care services such as home care was low. As we are following this group of people over time, we will be able to see if the use of social care increases as the condition progresses.<\/p>\n<p>The findings show that unpaid carers of people with dementia are disproportionately shouldering the costs of care \u2013 covering 75% of the total costs (\u00a32,928 over a 3 month period and \u00a311,712 a year) and giving upwards of 470 hours of their time over a three month period to care for people with dementia, equivalent to an average of 36 hours a week.<\/p>\n<p>Most of the people with dementia (87%) received help on a regular basis from friends or relatives. For nearly a third (30%), this included assistance with personal care.<\/p>\n<p>Relationship to carer, living alone, socio-economic group and income were all related to the likelihood of receiving social care. People living alone were nearly twice as likely as those living with others to use social care services.<\/p>\n<p>Two thirds of the people with dementia surveyed in IDEAL used aids and adaptations, most commonly mobility aids; 13% used pendant alarms and 12% calendar clocks.<\/p>\n<p>Those with Parkinson\u2019s disease dementia had almost double the average care costs compared to other dementias (\u00a38,609 over a 3-month period and \u00a334,436 a year). Estimated primary and community health care, social care and medication costs were highest for this group compared to those for people with other types of dementia. Total costs for women were lower than for men.<\/p>\n<p><strong><a href=\"https:\/\/content.iospress.com\/articles\/journal-of-alzheimers-disease\/jad215117\">Read the full article<\/a>: <\/strong>Published 2022, <em>IOS Press Content Library<\/em><\/p>\n<\/div>\n                <\/details>\n<details class=\"nhsuk-details\">\n                    <summary class=\"nhsuk-details__summary\">\n                        <span class=\"nhsuk-details__summary-text\">2022: IDEAL: Longitudinal predictors of informant-rated involvement of people with dementia in everyday decision-making<\/span>\n                    <\/summary>\n                    <div class=\"nhsuk-details__text\">\n<p><strong>Do people with dementia get to make decisions about their daily life?<\/strong><\/p>\n<p>We all make many decisions every day. We decide what to eat, what to wear, where to go and how to spend our time. These decisions are based on our personal preferences.<\/p>\n<p>We work with people with mild-to-moderate dementia who live at home. Often they want to make their own decisions. Sometimes, other people may make decisions for them. We wanted to find out which decisions people with dementia make and how these change over time.<\/p>\n<p>We asked family members who support people living with dementia about decision-making. We call these family members \u2018carers\u2019. We asked them the same questions again one year and two years later to see what changed over time.<\/p>\n<p>Carers told us about the kinds of decisions people with dementia make, and the kinds of decisions that they make for the person with dementia. Carers also told us:<\/p>\n<ul>\n<li>how much help they give the person with dementia<\/li>\n<li>how stressed they feel<\/li>\n<li>how well they get along with the person with dementia.<\/li>\n<\/ul>\n<p>People with dementia told us how well they get along with their carer.<\/p>\n<p>Carers told us that people with dementia make lots of everyday decisions. People with dementia are very involved in some decisions like when to get up and what to eat. They are less involved in other decisions like where to go and when to visit friends.<\/p>\n<p>Our results showed certain patterns:<\/p>\n<ul>\n<li>Women with dementia are more involved in making everyday decisions than men with dementia<\/li>\n<li>Carers who are husbands and wives of people with dementia make more decisions for them than carers who are daughters, sons or other relatives<\/li>\n<li>Carers make more decisions as the person\u2019s dementia progresses<\/li>\n<li>Carers who do not get along well with the person with dementia make more decisions<\/li>\n<li>Carers who are more stressed make more decisions for people with dementia.<\/li>\n<\/ul>\n<p>Overall, carers are doing well at involving people with dementia in decisions. Some carers may need support to be able to keep the person involved in making decisions. Carers who feel stressed or feel they do not get along with the person with dementia may need more general support.<\/p>\n<p><strong><a href=\"https:\/\/doi.org\/10.1177\/07334648221128558\">Read the full article<\/a>:<\/strong> Published October 2022, <em>Journal of Applied Gerontology<\/em><\/p>\n<\/div>\n                <\/details>\n<details class=\"nhsuk-details\">\n                    <summary class=\"nhsuk-details__summary\">\n                        <span class=\"nhsuk-details__summary-text\">2022: IDEAL: Positive experiences in dementia care-giving: Findings from the IDEAL programme<\/span>\n                    <\/summary>\n                    <div class=\"nhsuk-details__text\">\n<p><strong>What do carers find satisfying about caring?<\/strong><\/p>\n<p>Carers are family members, friends, or other supporters who provide help and support to people with dementia. Carers will have different experiences of caring. Some carers can find caring stressful. Some carers can also find caring to be a rewarding experience. In this study we explored what carers found satisfying when providing care.<\/p>\n<p>For this study we used information provided by carers who had taken part in the IDEAL programme. This study looks at what helps people to \u2018live well\u2019 with dementia.<\/p>\n<p>Carers were asked about the satisfactions they gained from providing care. Of the 900 carers who answered this question, 839 detailed satisfactions from caring. 49 carers had no satisfactions, and 12 were unsure.<\/p>\n<p>We looked at the answers from the carers who identified satisfactions. We found they talked about eight topics:<\/p>\n<p>Carers had \u2018grown\u2019 and learnt new skills through caring.<\/p>\n<ul>\n<li>Carers enjoyed spending time with the person with dementia.<\/li>\n<li>Carers were making a difference to the life of the person with dementia.<\/li>\n<li>Carers found it satisfying that they were fulfilling their duty by caring.<\/li>\n<li>Carers were helping the person with dementia to keep some of their independence.<\/li>\n<li>Carers felt they were providing good quality care.<\/li>\n<li>Carers were helping to improve the well-being of the person with dementia.<\/li>\n<li>Carers enjoyed their relationship with the person with dementia.<\/li>\n<\/ul>\n<p>The findings show that carers can identify positive experiences of caring. This helps us to think about the types of support that carers may find helpful. People working with carers should ask them about these positive experiences. This will help them to provide good support to carers.<\/p>\n<p><strong><a href=\"https:\/\/doi.org\/10.1017\/S0144686X22000526\">Read the full article<\/a>:<\/strong> Published June 2022, <em>Aging &amp; Society Journal <\/em><\/p>\n<\/div>\n                <\/details>\n<details class=\"nhsuk-details\">\n                    <summary class=\"nhsuk-details__summary\">\n                        <span class=\"nhsuk-details__summary-text\">2022: IDEAL: Are profiles of social, cultural, and economic capital related to living well with dementia? Longitudinal findings from the IDEAL cohort<\/span>\n                    <\/summary>\n                    <div class=\"nhsuk-details__text\">\n<p><strong>What resources do people with dementia have, and do these make a difference to \u2018living well\u2019?<\/strong><\/p>\n<p>The resources we have \u2013 such as friends, interests, and money \u2013 contribute to what we do and how we feel. They are important for \u2018living well\u2019, or quality of life. Having dementia could change our resources. For example, as time goes on it might be harder to do some kinds of activities or keep in contact with friends.<\/p>\n<p>We asked people living at home with mild-to-moderate dementia about the resources they have and about their quality of life. We asked them the same questions again one year and two years later.<\/p>\n<p>People with dementia did not get out and about much or get involved in many activities. A few had plenty of social contact, for example with friends, but most did not. Some people said they had enough money to spend, but most had limited funds. These resources did not change much over time.<\/p>\n<p>People\u2019s resources did vary, but the differences were generally small. There were no clear links with quality of life.<\/p>\n<p>The most striking finding was that people living at home with mild-tomoderate dementia have limited opportunities to socialize and do various activities. As a society we need to create more opportunities for people to do these things if they want to. We need to make sure these opportunities are accessible for people with limited funds.<\/p>\n<p><strong><a href=\"https:\/\/doi.org\/10.1016\/j.socscimed.2022.115603\">Read the full article:<\/a><\/strong> Published December 2022, <em>Social Science &amp; Medicine journal<\/em><\/p>\n<\/div>\n                <\/details>\n<details class=\"nhsuk-details\">\n                    <summary class=\"nhsuk-details__summary\">\n                        <span class=\"nhsuk-details__summary-text\">2022: IDEAL: Profiles of social, cultural, and economic capital as longitudinal predictors of stress, positive experiences of caring, and depression among carers of people with dementia<\/span>\n                    <\/summary>\n                    <div class=\"nhsuk-details__text\">\n<p><strong>Which aspects of life make a difference for carers?<\/strong><\/p>\n<p>We each have done different things in our lives. Some people spend longer studying, some do more years in work. There are differences in activities too: we might have hobbies, or visit family and friends. Our income is also important. We call these aspects of life resources.<\/p>\n<p>We wanted to find out what types of resources carers of people with dementia have. In this case, we were looking at people who care for their wife or husband. We also wanted to find out whether those carers with more resources are less stressed and depressed, and report more positive experiences of caring.<\/p>\n<p>Spousal carers of people with dementia told us about the resources they had. They also rated their level of stress and mood. Moreover, they told us about the good and bad aspects of being a carer. Carers answered the same questions again two more times one year apart.<\/p>\n<p>Overall, carers rarely met up with friends and family but spoke with them on the phone. Carers\u2019 income was similar to what other people their age had.<\/p>\n<p>Not everybody was the same. We found that carers could be placed into four groups.<\/p>\n<p>The first group had very low social, cultural, and economic resources. The second group had low social, cultural, and economic resources. Both groups did not have much money to spend. The third group had very high social and cultural resources and plenty of money to spend. The fourth group had high social and cultural resources and enough money to spend.<\/p>\n<p>Carers with fewer resources were slightly less stressed. They also reported more positive experiences of caring. However, they were more depressed.<\/p>\n<p>We need to better help people who are caring for their spouses with dementia so they can have some time off from caring, meet friends, and pursue hobbies. This would help them to maintain good wellbeing.<\/p>\n<p><strong><a href=\"https:\/\/doi.org\/10.1080\/13607863.2022.2098920\">Read the full article<\/a>:<\/strong> Published July 2022, <em>Aging &amp; Mental Health Journal<\/em><\/p>\n<\/div>\n                <\/details>\n<details class=\"nhsuk-details\">\n                    <summary class=\"nhsuk-details__summary\">\n                        <span class=\"nhsuk-details__summary-text\">2022: IDEAL: Dementia sub-type and living well: results from the Improving the experience of Dementia and Enhancing Active Life (IDEAL) study<\/span>\n                    <\/summary>\n                    <div class=\"nhsuk-details__text\">\n<p>There are several different types of dementia. Each type has different symptoms and challenges. These challenges can affect the ability to \u2018live well\u2019. People who are \u2018living well\u2019 are satisfied with their lives, and experience good quality of life and wellbeing. We wanted to find out whether the person\u2019s type of dementia makes it easier or harder to \u2018live well\u2019. We used information from 1283 people with dementia and their family carers taking part in the IDEAL study. IDEAL is following a large group of people with dementia and family carers in Great Britain over several years.<\/p>\n<p>We compared the \u2018living well\u2019 scores of people with different types of dementia. Alzheimer\u2019s disease was the most common type of dementia. People with some other types of dementia had lower \u2018living well\u2019 scores than people with Alzheimer\u2019s disease. These were vascular dementia, mixed Alzheimer\u2019s and vascular dementia, Parkinson\u2019s disease dementia and Lewy body dementia. Family carers of people with Parkinson\u2019s disease dementia and Lewy body dementia had lower \u2018living well\u2019 scores than family carers of people with Alzheimer\u2019s disease. Living with dementia is challenging for everyone. This study shows that it is harder to \u2018live well\u2019 with certain types of dementia. This helps us understand how to improve support for people with dementia and their family carers.<\/p>\n<p><strong><a href=\"https:\/\/doi.org\/10.1186\/s12916-018-1135-2\">Read the full article<\/a>:<\/strong> Published December 2022, <em>BMC Medicine Journal<\/em><\/p>\n<\/div>\n                <\/details>\n<details class=\"nhsuk-details\">\n                    <summary class=\"nhsuk-details__summary\">\n                        <span class=\"nhsuk-details__summary-text\">2022: New insights into the genetic etiology of Alzheimer\u2019s disease and related dementias<\/span>\n                    <\/summary>\n                    <div class=\"nhsuk-details__text\">\n<p>Characterization of the genetic landscape of Alzheimer\u2019s disease (AD) and related dementias (ADD) provides a unique opportunity for a better understanding of the associated pathophysiological processes. We performed a two-stage genome-wide association study totaling 111,326 clinically diagnosed\/\u2018proxy\u2019 AD cases and 677,663 controls. We found 75 risk loci, of which 42 were new at the time of analysis. Pathway enrichment analyses confirmed the involvement of amyloid\/tau pathways and highlighted microglia implication. Gene prioritization in the new loci identified 31 genes that were suggestive of new genetically associated processes, including the tumor necrosis factor alpha pathway through the linear ubiquitin chain assembly complex. We also built a new genetic risk score associated with the risk of future AD\/dementia or progression from mild cognitive impairment to AD\/dementia. The improvement in prediction led to a 1.6- to 1.9-fold increase in AD risk from the lowest to the highest decile, in addition to effects of age and the\u00a0<i>APOE<\/i>\u00a0\u03b54 allele.<\/p>\n<p><a href=\"https:\/\/www.nature.com\/articles\/s41588-022-01024-z\">Read the full article:<\/a> Published 2022, <em>Nature Genetics<\/em><\/p>\n<\/div>\n                <\/details>\n<details class=\"nhsuk-details\">\n                    <summary class=\"nhsuk-details__summary\">\n                        <span class=\"nhsuk-details__summary-text\"> 2021: NIDUS-Family: Supporting independence at home for people living with dementia: a qualitative ethnographic study of homecare<\/span>\n                    <\/summary>\n                    <div class=\"nhsuk-details__text\">\n<p>The aim of this ethnographic study was to investigate how homecare workers support or inhibit independence in people living with dementia.<\/p>\n<p>We undertook 100\u00a0h of participant observations with homecare workers (<i>n<\/i>\u2009=\u200916) supporting people living with dementia (<i>n<\/i>\u2009=\u200917); and 82 qualitative interviews with people living with dementia (<i>n<\/i>\u2009=\u200911), family carers (<i>n<\/i>\u2009=\u200922), homecare managers and support staff (<i>n<\/i>\u2009=\u200911), homecare workers (<i>n<\/i>\u2009=\u200919) and health and social care professionals (<i>n<\/i>\u2009=\u200919). We triangulated data and analysed findings thematically.<\/p>\n<p>We developed three themes: (1) independence and the home environment, highlighting ongoing negotiations between familiarity, suitability and safety for care; (2) independence and identity, exploring how homecare workers\u2019 understanding of their clients\u2019 identity can enable active participation in tasks and meaningful choices; and (3) independence and empowerment, considering the important position of homecare workers to advocate for clients living with dementia while navigating authoritative power amongst proxy decision-makers.<\/p>\n<p>We consider that person-centred care should also be home-centred, respecting the client\u2019s home as an extension of self. Homecare workers can use their understanding of clients\u2019 identities, alongside skills in providing choice and developing relationships of interdependence to engage clients in everyday tasks. Homecare workers are well placed to advocate for their client\u2019s voice within the care network, although their ability to do so is limited by their position within power structures.<\/p>\n<p><a href=\"https:\/\/link.springer.com\/article\/10.1007\/s00127-021-02084-y\">Read the full article<\/a>: Published 2021,\u00a0<em>Social Psychiatry and Psychiatric Epidemiology\u00a0<\/em><\/p>\n<\/div>\n                <\/details>\n<details class=\"nhsuk-details\">\n                    <summary class=\"nhsuk-details__summary\">\n                        <span class=\"nhsuk-details__summary-text\">2021: RADAR: Losartan to slow the progression of mild-to-moderate Alzheimer&#039;s disease through angiotensin targeting: the RADAR RCT<\/span>\n                    <\/summary>\n                    <div class=\"nhsuk-details__text\">\n<p>Alzheimer\u2019s disease is a disorder of memory in older individuals. High blood pressure in mid-life increases the risk of developing Alzheimer\u2019s disease. We and others have found that a biochemical pathway in the brain, which also influences blood pressure, may be more relevant in Alzheimer\u2019s disease than changes to blood pressure. This pathway, the renin\u2013angiotensin system, includes a small molecule called angiotensin II that is raised in brain tissue from people with Alzheimer\u2019s disease. As well as raising blood pressure, angiotensin II influences inflammation and chemical stress in brain cells and stops the release of chemicals involved in memory. Angiotensin II also enhances the production of key proteins (amyloid-\u03b2 and tau) that damage brain tissue in Alzheimer\u2019s disease. All of these damaging characteristics point to angiotensin II being a detrimental factor in Alzheimer\u2019s disease.<\/p>\n<p>We conducted a multicentre randomised clinical trial to test whether or not losartan, the first drug developed to reduce the function of angiotensin II, could slow the progression of Alzheimer\u2019s disease compared with placebo. We believed that reducing angiotensin II function would slow brain cell damage, brain shrinkage and memory problems in Alzheimer\u2019s disease while improving brain blood flow. We recruited 211 participants and their study partners through 23 centres across Great Britain and Northern Ireland. We used brain imaging techniques, 12 months apart, to measure changes in brain volume and, in a subset of people, levels of brain-related vascular damage and brain blood flow as indicators of disease. We also used established questionnaires to assess memory and thinking, quality of life and activities of daily living to explore if losartan brought any benefits. Unfortunately, we found no evidence that 12 months\u2019 treatment with losartan slowed the progression of Alzheimer\u2019s disease according to our main study measures. Although losartan was unsuccessful in this study design, other study designs testing related drugs may still be successful.<\/p>\n<p><strong><a href=\"https:\/\/doi.org\/10.3310\/eme08190\">Read the full article<\/a>: <\/strong>Published 2021, <em>NIHR Journals Library<\/em><\/p>\n<\/div>\n                <\/details>\n<details class=\"nhsuk-details\">\n                    <summary class=\"nhsuk-details__summary\">\n                        <span class=\"nhsuk-details__summary-text\">2021: Free-Cog: The Free-Cog study: A novel hybrid scale for the assessment of cognitive and executive function in dementia<\/span>\n                    <\/summary>\n                    <div class=\"nhsuk-details__text\">\n<p><strong>What was this research about and why was it important?<\/strong><\/p>\n<p>An estimated 1 in 14 people over the age of 65 living in the UK have dementia. Although we are yet to find a cure, early diagnosis and interventions can allow patients to live independently for longer. Therefore, early and efficient diagnosis is one of the most important tools in a clinician\u2019s arsenal. However, diagnosis can be complicated by the fact that that many types of dementia exist and, the specific pattern of damage within a person\u2019s brain will affect how individual symptoms present. Therefore, any test needs to be able to detect and pinpoint a range of symptoms. Being familiar with a range of clinical tests used to diagnose dementia, Professor Alistair Burns and his team noticed a problem with these existing tools. Not only were the majority subject to copyright, thus requiring payment for use, no single test combined measures of cognition (memory, visual and spatial function, language and fluency) with measures of executive function (social functioning, travel, self-care and safety in the home). It was this observation that sparked the idea for Free-Cog; a free-to-use assessment tool which combined tests of cognition and executive function into one global test, designed to be suitable for use in a busy clinical environment.<\/p>\n<p><strong>What did our patients say about taking part?<\/strong><\/p>\n<p>Patients and members of the public were involved in developing this project at a very early stage. Professor Burn\u2019s team worked with The Alzheimer\u2019s Society\u2019s Research Network to ensure that the format and wording of the test questions were tailored to patient\u2019s needs. This involvement appeared to be beneficial, since many patients who were involved in trialing out the Free-Cog assessment commented that they liked its \u2018conversational style\u2019 and that they felt more relaxed and confident taking this test than some other more commonly use assessments. \u201cIt didn\u2019t feel like an examination, it felt more like a TV quiz and was much better than the other assessment\u201d, \u201cMy father seemed more visibly relaxed completing the Free-Cog study then the previous assessment\u201d<\/p>\n<p><strong>What did the study find?<\/strong><\/p>\n<p>In total, 956 participants from across the UK took part in trialing the Free-Cog assessment. Many Greater Manchester patients fed back to our research nurses saying they found the experience interesting and enjoyable. The study showed that Free-Cog was similar to existing, routinely used, tests in its ability to differentiate between patients with Mild Cognitive Impairment (MCI) and Dementia and between healthy patients with no cognitive diagnosis and those with MCI. Despite some limitations, including a lack of specificity inherent in being a global scale and minimal written instructions, designed to make it easier for busy clinicians but which may be less acceptable for inexperienced staff; the Free-Cog assessment performed well and may have a number of benefits over current routinely used tests.<\/p>\n<p><strong>How will it improve services in the future?<\/strong><\/p>\n<p>This tool is free to use, measures both cognitive and executive functioning and is less likely to be perceived as a \u2018test\u2019 by patients meaning overall performance may be less impacted by patient anxiety. Combine these benefits with the finding that its performance is on par with other more commonly used tests and that it has a telephone consultation version (Tele Free-Cog) which also discriminates between patient groups, this makes Free-Cog a particularly powerful tool which may also adapt well to non-face-to-face setting. The Free-Cog will remain freely available in perpetuity. It is available to anyone interested in trialing it, translating it or validating it.<\/p>\n<p><strong><a href=\"https:\/\/www.ncbi.nlm.nih.gov\/pmc\/articles\/PMC7984170\/\">Read the full article<\/a>: <\/strong>Published 2021, <em>International Journal of Geriatric Psychiatry<\/em><\/p>\n<\/div>\n                <\/details>\n<details class=\"nhsuk-details\">\n                    <summary class=\"nhsuk-details__summary\">\n                        <span class=\"nhsuk-details__summary-text\">2021: LTCQ: Use of the Long-Term Conditions Questionnaire (LTCQ) for monitoring health-related quality of life in people affected by cognitive impairment including dementia: pilot study in UK memory clinic services<\/span>\n                    <\/summary>\n                    <div class=\"nhsuk-details__text\">\n<p>Diagnosis of dementia and mild cognitive impairment (MCI) is improving, but people affected by cognitive impairment need ongoing support to maintain a good quality of life. Current health and social care policy states that improved quality of life should be an outcome of effective services following diagnosis, but this is currently not being measured. The Long-Term Condition Questionnaire (LTCQ) is a patient-reported measure of \u2018living well with long-term health conditions\u2019 that could be used to monitor how well people are supported following a diagnosis of cognitive impairment. The purpose of this study was to test the use of LTCQ in English memory clinic settings. For the first phase of research, 12 people affected by cognitive impairment completed LTCQ during interviews and gave feedback about their experiences. A modified version of LTCQ was then completed through a survey taken by 105 people with a new diagnosis of MCI or dementia. Survey results showed that LTCQ scores were worse for patients with multiple long-term conditions (including MCI\/dementia) and for patients who required more help in completing the survey. But most patients were able to respond to LTCQ questions themselves, to directly report their quality of life. Sixty-one patients completed LTCQ again four months later, and changes in LTCQ scores reflected whether patients\u2019 health had gotten better or worse since diagnosis. We concluded that LTCQ could potentially be used to monitor quality of life following a diagnosis of cognitive impairment and should be tested further among larger numbers of patients.<\/p>\n<p><strong><a href=\"https:\/\/www.ncbi.nlm.nih.gov\/pmc\/articles\/PMC8178132\/\">Read the full article<\/a>: <\/strong>Published 2021, <em>Quality of Life Research<\/em><\/p>\n<\/div>\n                <\/details>\n<details class=\"nhsuk-details\">\n                    <summary class=\"nhsuk-details__summary\">\n                        <span class=\"nhsuk-details__summary-text\">2021: ASCOT: Measuring outcomes of people with dementia and their carers<\/span>\n                    <\/summary>\n                    <div class=\"nhsuk-details__text\">\n<p><strong>What was the study about?<\/strong><\/p>\n<p>We wanted to see whether the two questionnaires that the research team based at Personal Social Services Research Unit, University of Kent has developed are (1) easy to complete and (2) measure what they are intended to measure \u2013 that is, aspects of people\u2019s lives that might be affected by using social care services.<\/p>\n<p>In this study, we were especially interested in social care services that people use when they are living at home, like home care, day activities or support from a carers centre.<\/p>\n<p>The first questionnaire, called ASCOT-Carer, looks at aspects of life that are important to family and friends who look after someone. The second questionnaire, called ASCOT-Proxy, looks at aspects of life that are important to person living with dementia. ASCOT-Proxy was designed to collect information about someone who is unable to take part in surveys. In this study, we asked family and friends, who support someone with dementia, to fill in the questionnaire.<\/p>\n<p><strong>What did researchers learn from this study?<\/strong><\/p>\n<p>Both questionnaires have very low missing information. This indicates that carers of people living with dementia in England find the questionnaires easy to fill in. The results also confirmed that the questionnaires are reliable and measure what they were intended to measure. This means that we can use these questionnaires, with confidence, in future research. This will help us to understand whether, when and how different social care services improve people\u2019s lives.<\/p>\n<p>In addition, this study has shown that people living with dementia and their carers have high levels of unmet needs even when in contact with social care services. This shows that the needs of people with dementia and their carers are not always being fully understood and addressed. This is an important message for adult social services, social care providers and funders or decision-makers.<\/p>\n<p>We also found that some people are more likely to have unmet needs &#8211; especially, people with their own health problems and when the design of the home is not suitable for the person living with dementia. This suggests that social care, healthcare and housing services need to work better together.<\/p>\n<p><a href=\"https:\/\/www.pssru.ac.uk\/pub\/5878.pdf\">ASCOT study results<\/a><\/p>\n<\/div>\n                <\/details>\n<details class=\"nhsuk-details\">\n                    <summary class=\"nhsuk-details__summary\">\n                        <span class=\"nhsuk-details__summary-text\">2021: IDEAL Programme: Quality of life and well-being of carers of people with dementia: are there differences between working and nonworking carers? Results from the IDEAL program<\/span>\n                    <\/summary>\n                    <div class=\"nhsuk-details__text\">\n<p>Do caregivers of people with dementia who were also in regular employment (paid or voluntary) feel they have better quality of life and well-being compared to nonworking caregivers?<\/p>\n<p>We asked 1239 spouse, relative and friend carers who took part in the IDEAL programme to self-rate their quality of life and well-being, and to comment on other factors like their caregiving experience and social support. Our carers ranged in age from 26-96 years of age. Whatever their age, their gender, or their relationship to the care recipient (spouse, relative, friend), working carers reported higher quality of life score than carers who were not working. This may reflect the benefit of the sense of independence that supported work opportunities gives to carers. Whether they were working or not working, carers who had a good self-esteem and had found ways to reduce their stress levels felt better about their quality of life and well-being. Carers who had good social support, and who felt positive about the care they were providing and their own competence in providing good care reported higher quality of life and well-being scores. This is one of the biggest surveys comparing working and nonworking carers in the UK. It has revealed the value of supported work opportunities for people caring for people with dementia. It has also provided a clear message on how we can support and improve the health and well-being of the hundreds of thousands of people providing informal care for their relatives, by helping them to keep connected, to value themselves, their own skills and the huge importance of that caring role.<\/p>\n<p><strong><a href=\"http:\/\/sro.sussex.ac.uk\/id\/eprint\/90458\">Read the full article<\/a>: <\/strong>Published 2021, <em>Sussex Research Online<\/em><\/p>\n<p><strong>\u00a0<\/strong><\/div>\n                <\/details>\n<details class=\"nhsuk-details\">\n                    <summary class=\"nhsuk-details__summary\">\n                        <span class=\"nhsuk-details__summary-text\">2020: PrAISED: Deconditioning in people living with dementia during the COVID-19 pandemic: findings from the Promoting Activity, Independence and Stability in Early Dementia (PrAISED) process evaluation<\/span>\n                    <\/summary>\n                    <div class=\"nhsuk-details__text\">\n<p>Restrictions introduced in response to the COVID-19 pandemic led to an increased risk of deconditioning in the general population; a loss of function in movement, mental status or the ability to accomplish daily activities. This study aimed to identify the causes and effects of COVID-19 related deconditioning specifically in people living with dementia. Interviews were conducted remotely with 24 participants living with dementia, 19 carers and 15 therapists 2 months after the first national lockdown in March 2020 and again 2 months later. The content of these interviews was analysed and a self-reinforcing pattern was common. The lockdown made the person apathetic, demotivated, socially disengaged and frailer which reduced activity levels and this then reinforced the effects of deconditioning over time. This deconditioning occurs in the general population yet we also found that this was exacerbated by having dementia and that there were particular contributing factors specific to dementia. Such as the cognitive demand required by them to remember and maintain social distancing rules and then the negative effects of further restrictions imposed by their carers to reduce their breaches in following restrictions. Without external support, most participants lacked the motivation and cognitive abilities to keep active, however those that received remote support from therapists via video were able to better combat deconditioning. This study highlights the increased risk that people with dementia have to deconditioning and the importance of support and potential that tele-rehabilitation has as an effective strategy to reduce it.<\/p>\n<p><strong><a href=\"https:\/\/www.medrxiv.org\/content\/10.1101\/2020.11.16.20231100v1.full-text\">Read the full article<\/a>: <\/strong>Published 2020, <em>medRxiv<\/em><\/p>\n<\/div>\n                <\/details>\n<details class=\"nhsuk-details\">\n                    <summary class=\"nhsuk-details__summary\">\n                        <span class=\"nhsuk-details__summary-text\">2020: MADE: Minocycline 200 mg or 400 mg versus placebo for mild Alzheimer&#039;s disease: the MADE Phase II, three-arm RCT<\/span>\n                    <\/summary>\n                    <div class=\"nhsuk-details__text\">\n<p>Alzheimer\u2019s disease affects about 700,000 people in the UK and, although there are drug treatments that can modestly improve some of the symptoms, we do not yet have any treatments that slow down the progression of dementia.<\/p>\n<p>Minocycline is an antibiotic that has been shown to protect brain cells in a number of experimental and animal models of Alzheimer\u2019s disease. Minocycline is cheap and well tolerated. If it could significantly slow down the course of Alzheimer\u2019s disease, it could quickly be made available to large numbers of people with Alzheimer\u2019s disease worldwide. Although minocycline is probably one of the best current candidates for Alzheimer\u2019s disease modification, the current evidence can only suggest a potential benefit.<\/p>\n<p>A clinical trial was conducted to determine definitively whether or not minocycline is effective in slowing the decline in Alzheimer\u2019s disease. Long-term treatment effects of minocycline were investigated, with two doses of minocycline, on decline in cognitive function, including memory, attention and language, and ability to carry out essential functions of daily living, such as getting dressed, grooming and eating.<\/p>\n<p>Unfortunately, the study found that minocycline treatment did not have any measurable effect in slowing down the progression of Alzheimer\u2019s disease. Participants who took minocycline showed exactly the same worsening of their cognitive functioning and activities of daily living as those who were allocated to placebo treatment. The trial also established that minocycline at the high dose is poorly tolerated in patients with Alzheimer\u2019s disease, whereas the low dose of minocycline is well tolerated, with participants being no more likely to withdraw from trial medication than those taking placebo.<\/p>\n<p>One limitation of the study is that biomarkers were not used to confirm Alzheimer\u2019s disease diagnosis, as tests for biomarkers are not routinely available within the NHS. Compliance with medication was also worse than expected, with few patients in the high-dose arm completing 2 years\u2019 treatment and only moderate compliance in the low-dose and placebo treatment arms. It was difficult to obtain outcome assessments that resulted in unequal numbers of completed assessments across treatment arms, which could have biased the study\u2019s results. Having said that, additional analyses investigating potential bias have, reassuringly, shown the same pattern of results.<\/p>\n<p>Although disappointing, these results are important because they will guide further research into the search for a treatment. There is currently much interest in treating inflammatory changes in the brain in Alzheimer\u2019s disease and, as minocycline is a potent anti-inflammatory drug, the study\u2019s results will show researchers which pathways they should focus on.<\/p>\n<p><strong><a href=\"https:\/\/doi.org\/10.3310\/eme07020\">Read the full article<\/a>: <\/strong>Published 2020, <em>NIHR Journals Library<\/em><\/p>\n<\/div>\n                <\/details>\n<details class=\"nhsuk-details\">\n                    <summary class=\"nhsuk-details__summary\">\n                        <span class=\"nhsuk-details__summary-text\"> 2016: DOMINO-AD Trail: Cost-effectiveness of donepezil and memantine in moderate to severe Alzheimer&#039;s disease<\/span>\n                    <\/summary>\n                    <div class=\"nhsuk-details__text\">\n<p>No lay summary in original article.<\/p>\n<p><strong><a href=\"https:\/\/doi.org\/10.1002\/gps.4583\">Read the full article<\/a>:<\/strong> Published October 2016, <em>International Journal of Geriatric Psychiatry<\/em><\/p>\n<\/div>\n                <\/details>\n<p>&nbsp;<\/p>\n<h2><strong>Psychosis<\/strong><\/h2>\n<p><span class=\"TextRun SCXW156381783 BCX8\" lang=\"EN-GB\" xml:lang=\"EN-GB\" data-contrast=\"auto\"><span class=\"NormalTextRun SCXW156381783 BCX8\"><details class=\"nhsuk-details\">\n                    <summary class=\"nhsuk-details__summary\">\n                        <span class=\"nhsuk-details__summary-text\">2025: BI 425809 with adjunctive CACT in schizophrenia (BI 1346-0038)<\/span>\n                    <\/summary>\n                    <div class=\"nhsuk-details__text\"><\/span><\/span><\/p>\n<p>Schizophrenia is a complex psychiatric disorder which can impact cognitive function relating to processing speed, working memory and executive function. Cognitive impairment associated with schizophrenia (CIAS) predicts poor functional outcomes and is likely a barrier to medication adherence.\u00a0 Despite significant patient burden, there are no approved pharmacotherapies to treat symptoms of cognitive impairment associated with schizophrenia (CIAS).<\/p>\n<p>This double-blind, placebo-controlled, parallel-group Phase II trial assessed the efficacy and safety of pharmacological augmentation of at-home computerized cognitive training (CCT) with iclepertin (BI 425809, a glycine transporter-1 inhibitor). Participants with schizophrenia (aged 18\u201350 years) on stable antipsychotic therapy, who were compliant with CCT during the run-in period, were enrolled. Patients were randomized (1:1) to once daily iclepertin 10 mg or placebo for 12 weeks, and all patients completed adjunctive CCT.\u00a0 Results: Out of 200 randomized patients, 154 (77.0 %) completed the trial. At efficacy endpoint assessment, no differences were observed between treatment groups.<\/p>\n<p><a href=\"https:\/\/www.sciencedirect.com\/science\/article\/pii\/S2215001324000416?via%3Dihub\">Read the full article:<\/a> Published June 2025 in Schizophrenia Research: Cognition<\/p>\n<\/div>\n                <\/details>\n<p><span class=\"TextRun SCXW156381783 BCX8\" lang=\"EN-GB\" xml:lang=\"EN-GB\" data-contrast=\"auto\"><span class=\"NormalTextRun SCXW156381783 BCX8\"><details class=\"nhsuk-details\">\n                    <summary class=\"nhsuk-details__summary\">\n                        <span class=\"nhsuk-details__summary-text\">2023: TALLY: Biogen phase 2 study of BIIB104 in CIAS<\/span>\n                    <\/summary>\n                    <div class=\"nhsuk-details__text\"><\/span><\/span><\/p>\n<p><span data-contrast=\"auto\">Researchers were looking for a drug that may help people with cognitive impairment associated with schizophrenia (CIAS).<\/span><span data-ccp-props=\"{}\">\u00a0<\/span><\/p>\n<p><span data-contrast=\"auto\">Schizophrenia is a mental illness that has psychotic, negative, and cognitive symptoms. Although there are some drugs for schizophrenia, most of them focus on psychotic symptoms. Currently, there are no drugs for the cognitive symptoms of schizophrenia. For that reason, researchers wanted to see if a drug called BIIB104 can help cognitive ability in study participants with schizophrenia<\/span><span data-ccp-props=\"{}\">\u00a0<\/span><\/p>\n<p><span data-contrast=\"auto\">The study included 195 participants, 136 men and 59 women. Researchers used a computer program to randomly choose the drug each participant took; either BIIB104, 0.15 or 0.5 milligrams twice daily OR Placebo twice daily for 12 weeks.\u00a0<\/span><span data-ccp-props=\"{}\">\u00a0<\/span><\/p>\n<p><span data-contrast=\"auto\">Overall, the researchers in this study found that there was no difference in change in working memory between participants who took BIIB104 and those that took placebo. They also found that most adverse reactions were non-serious, and that they happened at a similar rate across the BIIB104 and placebo groups.<\/span><span data-ccp-props=\"{}\">\u00a0<\/span><\/p>\n<p><a href=\"https:\/\/www.biogentrialtransparency.com\/content\/dam\/global-development\/general\/biogen-trial-link\/educational\/en-us\/pdf\/lls\/english-master\/NCT03745820-LLS.pdf\">Read more:<\/a> Published in\u00a0February 2023 in\u00a0<em>Biogentrialtransparencey.com<\/em><\/p>\n<\/div>\n                <\/details>\n<details class=\"nhsuk-details\">\n                    <summary class=\"nhsuk-details__summary\">\n                        <span class=\"nhsuk-details__summary-text\">2023: SLEEPWELL: A targeted psychological treatment for sleep problems in young people at ultra-high risk of psychosis in England): a parallel group, single-blind, randomised controlled feasibility trial<\/span>\n                    <\/summary>\n                    <div class=\"nhsuk-details__text\">\n<p>New evidence has shown that poor sleep is a causal factor in the development of many mental health problems, including psychosis. Psychosis can have major consequences on psychological wellbeing, physical health, relationships, education, and employment. We would like fewer young people to develop psychosis.<\/p>\n<p>As disrupted sleep has proven to be a major causal factor, we have developed a psychological sleep treatment. This has been previously tested in a small study with 12 young people. The results are highly promising. This trial is a feasibility study, which will test the study procedures and develop the treatment further before we conduct a larger study to test if the sleep treatment works.<\/p>\n<p>40 people aged 14-25 who had difficulties sleeping and other difficulties, including worries about other people or hearing voices took part in the trial. The participants were randomly allocated to receive the sleep therapy in addition to their usual care or just continue with their usual care.<\/p>\n<p>The sleep therapy involved up to eight meetings with a clinical psychologist (therapist) to work on improving sleep and took place over about 12 weeks. Participants who did not get the sleep therapy were offered a one-off session with a therapist at the end of the study to talk about ideas to improve their sleep.<\/p>\n<p>Everyone who took part was asked to meet with a research assessor at the beginning of the study, after 3 months and after 9 months. During these meetings they were asked to complete questionnaires about sleep, how they&#8217;ve been feeling, and any other concerns they may have. At the end of the study 16 participants took part in an interview to talk about their experiences of the study.<\/p>\n<p>The results found people were keen to take part in the study. All participants provided data at the follow up assessments. There was a high uptake of therapy (20\/21 people completed at least 4 sessions) and the treatment was acceptable to participants. Compared to usual care, the sleep therapy led to large improvements in sleep and wider benefits on other mental health outcomes, including anxiety, depression, and worries about harm from others. These improvements remained at the later follow up (9 months).<\/p>\n<p><a href=\"https:\/\/www.thelancet.com\/journals\/lanpsy\/article\/PIIS2215-0366(23)00203-1\/fulltext\">Read the full article:<\/a> Published September 2023, <em>The\u00a0Lancet Psychiatry\u00a0<\/em><\/p>\n<\/div>\n                <\/details>\n<details class=\"nhsuk-details\">\n                    <summary class=\"nhsuk-details__summary\">\n                        <span class=\"nhsuk-details__summary-text\">2022: Development of the Carer Recovery Questionnaire<\/span>\n                    <\/summary>\n                    <div class=\"nhsuk-details__text\">\n<p>This project looked to understand more about the experiences of family carers of those with psychosis and schizophrenia. Carers do such a valuable job but often they don\u2019t get much support themselves. Understanding carers experiences can help mental health services to develop better support and training for carers. By supporting carers, this helps the carer to support their loved one.<\/p>\n<p>This project happened in different stages. For example, part of this project focused on reviewing of questionnaires; all the main questionnaires used for carers were reviewed. This was to see what questionnaires were already available and whether they measured personal recovery effectively. From this, the team developed a new questionnaire to discuss with 10 carers and receive detail feedback. Main findings: \u2022The review (Hilton, 2016) showed there was no questionnaire that measured personal recovery for carers.<\/p>\n<p>The interviews: found that carers did not relate to the term personal recovery, however different facets of recovery were experienced such as acceptance, adaptation, resilience, and personal growth. \u2022 The development of the questionnaire: the results from the interviews showed I needed to change direction with the questionnaire as the term \u2018personal recovery\u2019 did not land well with carers. This led to the development of the Carer Adaptation and Resilience Scale (CARS). The questionnaire testing study showed the CARS had a clear structure and measures the different aspects of personal recovery well.<\/p>\n<p>The final questionnaire is now freely available for anyone to use, and the publication of findings is in process. Lay summary from Dr Claire Hilton &#8211; lead on this study with reference to article linked below.<\/p>\n<p>Read the full article: Published July 2022 in <em>Frontiers in Psychology\u00a0<\/em><\/p>\n<\/div>\n                <\/details>\n<details class=\"nhsuk-details\">\n                    <summary class=\"nhsuk-details__summary\">\n                        <span class=\"nhsuk-details__summary-text\">2019: CIRCLE Trial: A contingency management intervention to reduce cannabis use and time to relapse in early psychosis: the CIRCLE RCT<\/span>\n                    <\/summary>\n                    <div class=\"nhsuk-details__text\">\n<p>A large proportion of people with psychosis use cannabis, despite the negative impact that it has on their recovery. So far, a clearly effective way of helping young people in the early stages of psychosis to cut down their cannabis use has not been found. The CIRCLE trial investigated if an approach known as contingency management (CM) would be beneficial for this group. This approach involves offering voucher rewards for not using cannabis. It has been effective in addressing drug use problems in general, but there is not much evidence about its effects on cannabis use in those with psychosis.<\/p>\n<p>A total of 551 service users with psychosis who used cannabis agreed to enter the trial. Half of the sample group was chosen by a chance method to receive CM. The other half formed a comparison group. The CM group received shopping vouchers if urine samples showed that they had not used cannabis for the previous week, measured over 12 weekly sessions. Participants could obtain \u00a3240-worth of vouchers if they did not use cannabis during the treatment period. The participants in both groups were also offered a six-session psychoeducation programme about the pros and cons of cannabis use and ways to reduce use of it.<\/p>\n<p>The main comparison in the trial was the average length of time in each group before a relapse of psychosis occurred, which was recorded for each participant over 18 months after they joined the trial. The results found no difference between the two trial groups in this measure. Furthermore, there were no differences found between the groups in terms of the levels of cannabis use, clinical symptoms, or engagement with work or education. However, a cost-effectiveness analysis found an 85% chance of CM being more effective than the treatment-as-usual psychoeducation package, which appears to be because of the lower use of inpatient services by those receiving CM. However, it is difficult to understand why this was, because there was no drop in cannabis use. The results suggest that CM is unlikely to be clinically effective and that alternative treatments are still needed.<\/p>\n<p><a href=\"https:\/\/doi.org\/10.3310\/hta23450\"><strong>Read the full article:<\/strong><\/a> Published August 2019, <em>Health Technology Assessment Journal<\/em><\/p>\n<\/div>\n                <\/details>\n<details class=\"nhsuk-details\">\n                    <summary class=\"nhsuk-details__summary\">\n                        <span class=\"nhsuk-details__summary-text\"> 2019: SCIMITAR+: Smoking cessation for people with severe mental illness (SCIMITAR+): a pragmatic randomised controlled trial<\/span>\n                    <\/summary>\n                    <div class=\"nhsuk-details__text\">\n<p>No lay summary in original article.<\/p>\n<p><strong><a href=\"https:\/\/doi.org\/10.1016\/S2215-0366(19)30047-1\">Read the full article<\/a>:<\/strong> Published April 2019, <em>The Lancet Psychiatry Journal<\/em><\/p>\n<\/div>\n                <\/details>\n<p><span class=\"TextRun SCXW56933961 BCX8\" lang=\"EN-GB\" xml:lang=\"EN-GB\" data-contrast=\"auto\"><span class=\"NormalTextRun SCXW56933961 BCX8\"><details class=\"nhsuk-details\">\n                    <summary class=\"nhsuk-details__summary\">\n                        <span class=\"nhsuk-details__summary-text\">2019: ENLIGHTEN: ALK3831-A308 Long term safety extension study of ALKS3831 (MENT 35632)<\/span>\n                    <\/summary>\n                    <div class=\"nhsuk-details__text\"><\/span><\/span><\/p>\n<p><span data-contrast=\"auto\">ALKS 3831, currently under development for the treatment of schizophrenia, is composed of a flexible dose of olanzapine and a fixed dose of 10 mg of samidorphan. Samidorphan is intended to mitigate weight gain associated with olanzapine treatment alone. Here, we report the safety, tolerability and efficacy of ALKS 3831 in participants with schizophrenia that were enrolled in a phase 3, 52 week open-label extension study. Participants had completed a phase 3, 4-week, double-blind, inpatient acute efficacy study of ALKS 3831 compared to olanzapine or placebo.<\/span><span data-ccp-props=\"{}\">\u00a0<\/span><\/p>\n<p><span data-contrast=\"auto\">Participants were switched from either ALKS 3831, olanzapine or placebo from the previous study to receive treatment with ALKS 3831 10\/10 (10 mg olanzapine\/10 mg samidorphan) as investigators were blinded to previous treatment. Subsequently, treatment could be increased to 15\/10 or 20\/10 at any time during the study at the discretion of the Investigator. Study assessments included adverse event monitoring, clinical laboratory testing, evaluation of extrapyramidal symptoms etc.\u00a0<\/span><span data-ccp-props=\"{}\">\u00a0<\/span><\/p>\n<p><span data-contrast=\"auto\">Results: ALKS 3831 was generally well tolerated with a safety profile that supports long-term effective treatment. Over the course of this 52-week study, there was a significant improvement in schizophrenia symptoms.<\/span><span data-ccp-props=\"{}\">\u00a0<\/span><\/p>\n<p><a href=\"https:\/\/academic.oup.com\/schizophreniabulletin\/article\/45\/Supplement_2\/S212\/5434415\">Read the full article:<\/a> Published in April 2019 in The Journal of Psychosis and Related Disorders<\/p>\n<\/div>\n                <\/details>\n<details class=\"nhsuk-details\">\n                    <summary class=\"nhsuk-details__summary\">\n                        <span class=\"nhsuk-details__summary-text\">Thoughts about physical activity: questionnaire study <\/span>\n                    <\/summary>\n                    <div class=\"nhsuk-details__text\">\n<p>Many people who experience psychosis spend too much time sitting down and not enough time exercising. In order to design effective treatments to help people be more active we need to understand what helps and hinders physical activity.<\/p>\n<p>A previous study by this team (\u201cGetting more physically active: finding out what helps and hinders\u201d; REC reference 21\/WA\/0285), in which we spoke in depth to 51 people with psychosis, staff and carers, indicates that the thoughts people have about themselves, the world and others impact upon the physical activity they do. It is therefore important that we develop ways of assessing problematic thoughts, which can later be targeted in treatment. The next step is to develop four questionnaires: 1) Reasons to be active 2) Reasons to be less active 3) Reasons to stand 4) Reasons to sit.<\/p>\n<p>The items making up each of these questionnaires have come from i) interviews and focus groups with people who have psychosis, informal carers and staff ii) a lived experience advisory panel. The data from the questionnaires will not only help to create a clinically useful measure that can be used by many different health professionals, but the results will also give indications about how thoughts about physical activity relate to other experiences that people have (for example, how low mood might relate to our thoughts about activity).<\/p>\n<p>Over 600 patients with diagnoses of psychosis will be invited to answer a pack of questionnaires, and provide some brief demographic information. Roughly half participants will be invited to answer questions in pack 1 including the two new questionnaires relating to thoughts about exercise. The other half will be invited to answer questions in pack 2 including the two new questionnaires relating to thoughts about sitting. After completing the first pack a subgroup of around 100 participants will be asked to repeat two of the measures one week after initial participation, for test-retest analysis.<\/p>\n<p>In total; 917 participants took part between 6th March, 2023 to 19th February, 2024. 563 patients completed the physical activity lists and 523 patients completed the sedentary behaviour lists, with 169 patients completing both questionnaires. 620 (67.6%) patients were men and 286 (31.2%) patients were women. The average age was 42.9 years. Statistical analyses showed that the new questionnaires were strong. They related to the other questionnaires that measured movement, but not very strongly. Making sense of the results; there are lots of thoughts that drive movement for patients with psychosis.<\/p>\n<p>Some of the thoughts are similar for physical activity and sedentary behaviour, and some are more specific to only physical activity or only sedentary behaviour. The thoughts that seem to be important could be good targets for future treatments to increase movement. The next step is to find out whether we can change the thoughts and if so, whether this leads to more movement..<\/p>\n<p><a href=\"https:\/\/www.hra.nhs.uk\/planning-and-improving-research\/application-summaries\/research-summaries\/thoughts-about-physical-activity-questionnaire-study\/\">Read more:<\/a> Published on Health Research Authority.<\/p>\n<\/div>\n                <\/details>\n<h2><strong>Mood Disorders<\/strong><\/h2>\n<details class=\"nhsuk-details\">\n                    <summary class=\"nhsuk-details__summary\">\n                        <span class=\"nhsuk-details__summary-text\">2025: LQD: Lithium and Quetiapine for TRD: Clinical and cost-effectiveness of lithium versus quetiapine augmentation for treatment-resistant depression: a pragmatic, open-label, parallel-group, randomised controlled superiority trial in the UK<\/span>\n                    <\/summary>\n                    <div class=\"nhsuk-details__text\">\n<p>Lithium and quetiapine are first-line augmentation options for treatment-resistant depression; however, few studies have compared them directly, and none for longer than 8 weeks. We aimed to assess whether quetiapine augmentation therapy is more clinically effective and cost-effective than lithium for patients with treatment-resistant depression over 12 months.<\/p>\n<p>Eligible participants were adults (aged \u226518 years) with a current episode of major depressive disorder meeting DSM-5 criteria, with a score of 14 or higher on the HDRS at screening who had responded inadequately to two or more therapeutic antidepressant trials. Exclusion criteria included having a diagnosis of bipolar disorder or current psychosis.<\/p>\n<p>Participants were randomly assigned (1:1) to the decision to prescribe lithium or quetiapine, stratified by site, depression severity, and treatment resistance, using block randomisation with randomly varying block sizes. Results of the trial suggest that quetiapine is more clinically effective than lithium as a first-line augmentation option for reducing symptoms of depression in the long-term management of treatment-resistant depression, and is probably more cost-effective than lithium.<\/p>\n<p><a href=\"https:\/\/www.sciencedirect.com\/science\/article\/pii\/S2215036625000288?ref=pdf_download&amp;fr=RR-2&amp;rr=9495b6447c084189\">Read the full article<\/a>: Published April 2025 in\u00a0<em>The Lancet Psychiatry<\/em>.<\/p>\n<\/div>\n                <\/details>\n<p><span class=\"NormalTextRun SCXW167358996 BCX8\"><details class=\"nhsuk-details\">\n                    <summary class=\"nhsuk-details__summary\">\n                        <span class=\"nhsuk-details__summary-text\">2024: CIASP-ID: Development and psychometric properties of the Clinical Anxiety Scale for People with Intellectual Disabilities<\/span>\n                    <\/summary>\n                    <div class=\"nhsuk-details__text\"><\/span><\/p>\n<p><span data-contrast=\"auto\">There is a critical need for the development of dependable and valid anxiety assessment tools suitable for people with moderate to severe intellectual disabilities, particularly those who speak few or no words. Distinguishing anxiety from distress caused by physical discomfort (pain) or characteristics associated with autism, prevalent in this population, necessitates specialised assessment tools. This study (a) developed a parent-report anxiety questionnaire tailored for individuals with severe to moderate intellectual disabilities, potentially with a co-diagnosis of autism, and (b) evaluated the psychometric attributes of this novel measure.<\/span><span data-ccp-props=\"{}\">\u00a0<\/span><\/p>\n<p><span data-contrast=\"auto\">In total, 314 parents or caregivers of people with intellectual disabilities were recruited.<\/span><span data-ccp-props=\"{}\">\u00a0<\/span><\/p>\n<p><span data-contrast=\"auto\">Findings: Individuals diagnosed with both autism and anxiety exhibited significantly higher scores on the anxiety subscale compared to those without an anxiety diagnosis, while showing no difference in autism characteristic scores.<\/span><span data-ccp-props=\"{}\">\u00a0<\/span><\/p>\n<p><span data-contrast=\"auto\">The findings indicate that the Clinical Anxiety Scale for People with Intellectual Disabilities is a promising measure for use across diverse diagnostic groups, varying communication abilities, and with people with moderate to severe intellectual disabilities.<\/span><span data-ccp-props=\"{}\">\u00a0<\/span><\/p>\n<p><a href=\"https:\/\/publications.aston.ac.uk\/id\/eprint\/46522\/1\/JE_Mingins_et_al_Development_and_psychometric_properties_of_the_Clinical_Anxiety_Scale_for_People_w_Intellectual_Disabilities_CIASP_ID.pdf\">Read the full article:<\/a> Published July 2024 in the <em>Journal of\u00a0 Neurodevelopmental Disorders\u00a0<\/em><\/p>\n<\/div>\n                <\/details>\n<details class=\"nhsuk-details\">\n                    <summary class=\"nhsuk-details__summary\">\n                        <span class=\"nhsuk-details__summary-text\">2023: The IBER study: a feasibility randomised controlled trial of imagery based emotion regulation for the treatment of anxiety in bipolar disorder<\/span>\n                    <\/summary>\n                    <div class=\"nhsuk-details__text\">\n<p>No lay summary in original article.<\/p>\n<p><strong>Read the full article:<\/strong> Published July 2023, <em>International Journal of Bipolar Disorder<\/em><\/p>\n<\/div>\n                <\/details>\n<details class=\"nhsuk-details\">\n                    <summary class=\"nhsuk-details__summary\">\n                        <span class=\"nhsuk-details__summary-text\">2020: REACT RCT Study: A web-based, peer-supported self-management intervention to reduce distress in relatives of people with psychosis or bipolar disorder<\/span>\n                    <\/summary>\n                    <div class=\"nhsuk-details__text\">\n<p>Relatives of people with severe mental health problems need better access to information and emotional support. The Relatives\u2019 Education And Coping Toolkit (REACT) is a website designed to do this. It includes lots of information presented in text and video, an online forum for relatives to share knowledge and experience, a messaging system where they can ask questions in confidence and a comprehensive directory of contact details for national organisations offering relevant support. Trained relatives support the forum and messaging.<\/p>\n<p>In the UK, we recruited 800 relatives of people with severe mental health problems: all were aged \u2265\u200916 years, had high levels of distress, had access to the internet and wanted help. We divided them into two equal groups: one group received REACT (including the resource directory), whereas the other group received the resource directory only. To ensure that there were no differences between groups at the start, relatives were allocated to the two groups randomly, so they had an equal chance of being in either group. We followed up with both groups at 12 and 24 weeks, and received data from approximately three-quarters of the participants.<\/p>\n<p>This trial found that REACT was acceptable, safe and inexpensive to deliver (\u00a362.27 per relative), compared with face-to-face interventions, and that relatives using it felt well supported. However, once we accounted for missing data (relatives who dropped out of the trial or did not complete the follow-up questionnaires), there were no significant differences between the groups.<\/p>\n<p>There was no evidence that REACT increased relatives\u2019 quality of life or saved money for the NHS.<\/p>\n<p><a href=\"https:\/\/pubmed.ncbi.nlm.nih.gov\/32608353\/\">Read the full article:<\/a> Published June 2020, <em>Health Technology Assessment Journal<\/em><\/p>\n<\/div>\n                <\/details>\n<h2><strong>Other<\/strong><\/h2>\n<details class=\"nhsuk-details\">\n                    <summary class=\"nhsuk-details__summary\">\n                        <span class=\"nhsuk-details__summary-text\">2026: iACT4CARERS: Clinical effectiveness of internet-delivered self-help Aacceptance and Commitment Therapy for family carers of people with dementia (iACT4CARERS): a multicentre, parallel, randomised controlled trial<\/span>\n                    <\/summary>\n                    <div class=\"nhsuk-details__text\">\n<p>As dementia prevalence rises globally, unpaid family carers provide most care and face high mental health risk. Existing psychological interventions offer limited benefit for anxiety in this population. We evaluated the effectiveness of an internet-delivered, self-help Acceptance and Commitment Therapy intervention with minimal non-expert therapist support (iACT4CARERS) to reduce anxiety in dementia family carers.<\/p>\n<p>We conducted a multi-site, single-blind, parallel-group, randomised controlled trial across UK national healthcare services. Eligible participants were family carers of a person with dementia and reported anxiety symptoms (Generalised Anxiety Disorder-7 [GAD-7] score \u22655). Participants were allocated (1:1) to iACT4CARERS plus treatment-as-usual or treatment-as-usual alone, using computer-generated randomisation with minimisation by ethnicity and baseline anxiety. The intervention comprised an eight-session self-help programme guided by non-expert therapists. Outcome assessors and the lead statistician were blinded to allocation. The primary outcome was anxiety symptoms, assessed using the GAD-7 at 12-weeks post-randomisation. Analyses followed the intention-to-treat principle using linear regression models. The trial was pre-registered with ISRCTN (45995725).<\/p>\n<p>Between November 1, 2023, and January 14, 2025, 902 individuals were referred: 567 (63%) were assessed for eligibility and 496 (87%) were randomised (249 to intervention; 247 to control). 397\/496 (80%) were female. Primary outcome data were available for 398\/496 participants (80%). After adjustment for baseline anxiety, ethnicity, and education, iACT4CARERS plus treatment-as-usual significantly reduced anxiety at 12 weeks compared with treatment-as-usual alone (adjusted mean difference \u22122.62, 95% CI \u22123.47 to \u22121.77; p &lt; 0.0001; d = 0.53), with participants in the intervention group showing clinically meaningful improvement. Three non-intervention-related adverse events were reported; no serious adverse events occurred.<\/p>\n<p><a href=\"https:\/\/www.thelancet.com\/journals\/lanepe\/article\/PIIS2666-7762(26)00178-X\/fulltext\">Read more<\/a>: Published August 2026,\u00a0<em>The Lancet Regional Health<\/em><br \/>\n<\/div>\n                <\/details>\n<details class=\"nhsuk-details\">\n                    <summary class=\"nhsuk-details__summary\">\n                        <span class=\"nhsuk-details__summary-text\">2023: Spectrum 10K<\/span>\n                    <\/summary>\n                    <div class=\"nhsuk-details__text\">\n<p>Spectrum 10K is a research project led by the Autism Research Centre3 at the University of Cambridge. The study aims to investigate genetic and environmental factors that contribute to autism, cooccurring conditions, and the wellbeing of autistic people. In particular, the study aims to identify common genetic variants associated with autism, autistic traits, and chronic health conditions that occur more often in autistic people (such as epilepsy and gastrointestinal pain).<\/p>\n<p>A report was created in response to this study, it has been co-designed by autistic people. The report uses qualitative methadology supplemented by some closed quantitative questions which are easier for some autistic people to answer. We will be proposing new research studies in response to the findings from the consultation, which found that many autistic people support research into co-occurring mental and physical health conditions.<\/p>\n<p>These studies will be further shaped by engagement with autistic people and possible topics include: &#8211; The impact on late diagnosis of ADHD and autism on physical and mental health &#8211; The health challenges faced by autistic women &#8211; Whether autistic people experience greater prevalence and severity of neuroimmune conditions, and \u2013 if so \u2013 why.<\/p>\n<p>These studies will use existing genetic and health registers and will not require new data collection. They all aim to build stronger evidence base so that in the future this evidence will lead to better ways to promote good health and prevent and treat ill health in autistic people.<\/p>\n<p><a href=\"https:\/\/static1.squarespace.com\/static\/56f16de77da24f3e5612733b\/t\/67a1d40bc8f51d056112421f\/1738658829482\/S10KConsultation+Phase+3+Report+-+FINAL+-+220923.pdf\">Read more:<\/a> Published September 2023, independent report.<\/p>\n<\/div>\n                <\/details>\n<details class=\"nhsuk-details\">\n                    <summary class=\"nhsuk-details__summary\">\n                        <span class=\"nhsuk-details__summary-text\">2023: SAFE-PIT: The Self-harm, Assessment, Formulation, Engagement Trial of Psychodynamic Interpersonal Therapy<\/span>\n                    <\/summary>\n                    <div class=\"nhsuk-details__text\">\n<p>We set up this trial to find out whether a type of brief therapy, psychodynamic interpersonal therapy (PIT), helps people who attend an emergency department (ED) after an episode of self-harm (SH). We are interested in whether PIT helps people reduce future SH, ED attendance and improve their mental health and quality of life.<\/p>\n<p>We will also measure costs and potential cost-savings as this is important for the NHS. PIT therapy involves 4 weekly sessions and is intended for people who have 3 or fewer SH episodes. People who SH more frequently require more intensive treatment, and we have a separate study which will assess a more intensive treatment for this group.<\/p>\n<p>Standard care involves a full psychosocial assessment and a care plan. Mental health nurses who work in EDs approached people who have attended hospital following SH to see if they are interested in taking part, assuming the study is suitable for them. Those who agree to take part will be allocated by chance to one of 2 groups; PIT as well as standard care or standard care only. We have involved users with experience of SH in designing this study and have a co-applicant who has personal experience of SH and considerable experience of raising awareness and advocating for better mental health care.<\/p>\n<p><a href=\"https:\/\/www.hra.nhs.uk\/planning-and-improving-research\/application-summaries\/research-summaries\/safepit\/\">Read more<\/a>: Assumed publication year 2023,<em> Health Research Authority\u00a0<\/em><\/p>\n<\/div>\n                <\/details>\n<details class=\"nhsuk-details\">\n                    <summary class=\"nhsuk-details__summary\">\n                        <span class=\"nhsuk-details__summary-text\">2021: Preferences for group arts therapies: a cross-sectional survey of mental health patients and the general population<\/span>\n                    <\/summary>\n                    <div class=\"nhsuk-details__text\">\n<p>No lay summary in original article.<\/p>\n<p><a href=\"https:\/\/doi.org\/10.1136\/bmjopen-2021-051173\"><strong>Read the full article<\/strong><\/a>: Published July 2021,<em> BMJ Open<\/em><\/p>\n<\/div>\n                <\/details>\n<details class=\"nhsuk-details\">\n                    <summary class=\"nhsuk-details__summary\">\n                        <span class=\"nhsuk-details__summary-text\">2020: Sleepio: Digital Cognitive Behavioral Therapy for Insomnia for Adolescents With Mental Health Problems: Feasibility Open Trial<\/span>\n                    <\/summary>\n                    <div class=\"nhsuk-details__text\">\n<p><strong>Background<\/strong><\/p>\n<p>Insomnia in adolescents is common and is associated with poor mental health including anxiety and depression. Although common, insomnia in adolescents with mental health problems is rarely treated. We do not know whether treating adolescent insomnia will be helpful or whether this might have any effects on their mental health.<\/p>\n<p><strong>What we<\/strong> did?<\/p>\n<p>We offered young people aged 14-17, with insomnia, attending specialist child and adolescent mental health services an online sleep intervention (Sleepio).<\/p>\n<p>We asked young people to complete assessments of sleep, mood and anxiety before and after the programme. We asked whether they were satisfied with the programme and if they would recommend it to other young people.<\/p>\n<p><strong>What we found<\/strong>:<\/p>\n<ul>\n<li>The thirty-nine adolescents who elected to use the sleep programme had very poor sleep. They spent an average of 9.6 hrs in bed each night but were only asleep for 5.1. hours.<\/li>\n<li>Three quarters were not having any treatment for their sleep. The remaining quarter were prescribed medication.<\/li>\n<li>Half of the adolescents completed the six session sleep programme. 84% found Sleepio helpful, 95% would recommend it to a friend and 37% prefered an online intervention.<\/li>\n<li>There were significant improvements in sleep, mood and anxiety after using Sleepio.<\/li>\n<\/ul>\n<p><strong>What does this mean<\/strong><\/p>\n<ul>\n<li>Online sleep interventions for young people with mental health problems are acceptable and improve sleep and mental health<\/li>\n<\/ul>\n<p><strong>What next?<\/strong><\/p>\n<ul>\n<li>Further well designed research is needed to fully establish the effects of online sleep programmes on the sleep and mental health of adolescents.<\/li>\n<\/ul>\n<p><strong>Read the full article:<\/strong> Published March 2020, <em>JMIR Mental Health Journal<\/em><\/p>\n<\/div>\n                <\/details>\n<details class=\"nhsuk-details\">\n                    <summary class=\"nhsuk-details__summary\">\n                        <span class=\"nhsuk-details__summary-text\">2020: CoACtION: Cultural Adaptations in Clinical InteractiONs (CoACtION): a multi-site comparative study to assess what cultural adaptations are made by clinicians in different settings<\/span>\n                    <\/summary>\n                    <div class=\"nhsuk-details__text\">\n<p>No lay summary in original article.<\/p>\n<p><a href=\"https:\/\/doi.org\/10.1080\/09540261.2020.1750818\"><strong>Read the full article<\/strong><\/a>: Published May 2020, <em>Internation review of psychiatry journal<\/em><\/p>\n<\/div>\n                <\/details>\n<details class=\"nhsuk-details\">\n                    <summary class=\"nhsuk-details__summary\">\n                        <span class=\"nhsuk-details__summary-text\">2020: CARMEN Study: Evaluation of a point of care device in improving physical health check uptake in two community mental health teams<\/span>\n                    <\/summary>\n                    <div class=\"nhsuk-details__text\">\n<p>No lay summary in original article.<\/p>\n<p><a href=\"https:\/\/doi.org\/10.1093\/schbul\/sbaa031.305\"><strong>Read the full article<\/strong><\/a>: Published April 2020, <em>Schizophrenia Bulletin<\/em><\/p>\n<\/div>\n                <\/details>\n<details class=\"nhsuk-details\">\n                    <summary class=\"nhsuk-details__summary\">\n                        <span class=\"nhsuk-details__summary-text\">2018: The role of the assistant practitioner in the clinical setting: a focus group study<\/span>\n                    <\/summary>\n                    <div class=\"nhsuk-details__text\">\n<p>No lay summary in original article.<\/p>\n<p><a href=\"https:\/\/doi.org\/10.1186\/s12913-018-3506-y\"><strong>Read the full article<\/strong><\/a>: Published Sep 2018, <em>BMC Health Services Research Journal<\/em><\/p>\n<\/div>\n                <\/details>\n","protected":false},"excerpt":{"rendered":"<p>There are many ways to get involved with research at Oxford Health NHS Foundation Trust. We are hugely grateful to all those people who take part in our research and want to give participants the opportunity to be updated on the outcomes of the studies they have been involved with. To do this we are [&hellip;]<\/p>\n","protected":false},"author":1,"featured_media":0,"parent":1349,"menu_order":1,"comment_status":"closed","ping_status":"closed","template":"","meta":{"_acf_changed":false,"_relevanssi_hide_post":"","_relevanssi_hide_content":"","_relevanssi_pin_for_all":"","_relevanssi_pin_keywords":"","_relevanssi_unpin_keywords":"","_relevanssi_related_keywords":"","_relevanssi_related_include_ids":"","_relevanssi_related_exclude_ids":"","_relevanssi_related_no_append":"","_relevanssi_related_not_related":"","_relevanssi_related_posts":"","_relevanssi_noindex_reason":"","footnotes":""},"class_list":["post-1222","page","type-page","status-publish","hentry"],"acf":[],"_links":{"self":[{"href":"https:\/\/oxfordhealth.nhs.uk\/research\/wp-json\/wp\/v2\/pages\/1222","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/oxfordhealth.nhs.uk\/research\/wp-json\/wp\/v2\/pages"}],"about":[{"href":"https:\/\/oxfordhealth.nhs.uk\/research\/wp-json\/wp\/v2\/types\/page"}],"author":[{"embeddable":true,"href":"https:\/\/oxfordhealth.nhs.uk\/research\/wp-json\/wp\/v2\/users\/1"}],"replies":[{"embeddable":true,"href":"https:\/\/oxfordhealth.nhs.uk\/research\/wp-json\/wp\/v2\/comments?post=1222"}],"version-history":[{"count":29,"href":"https:\/\/oxfordhealth.nhs.uk\/research\/wp-json\/wp\/v2\/pages\/1222\/revisions"}],"predecessor-version":[{"id":1906,"href":"https:\/\/oxfordhealth.nhs.uk\/research\/wp-json\/wp\/v2\/pages\/1222\/revisions\/1906"}],"up":[{"embeddable":true,"href":"https:\/\/oxfordhealth.nhs.uk\/research\/wp-json\/wp\/v2\/pages\/1349"}],"wp:attachment":[{"href":"https:\/\/oxfordhealth.nhs.uk\/research\/wp-json\/wp\/v2\/media?parent=1222"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}